Investor Relations

Financial calendar

 

Subscribe to calendar

Latest press releases

ExpreS2ion to present in upcoming investor and scientific events

Hørsholm, Denmark, 31 October2024 – ExpreS2ion Biotech Holding AB’s subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate in upcoming investor and scientific events, including BIO-Europe, the Protein & Antibody Engineering Summit Europe, a 2024 Third Quarter Results Webinar, and the LSX Investival Showcase.

Read more

The Board of Directors of ExpreS2ion Biotech Holding AB (publ) has resolved on the record date for the reverse share split

Hørsholm, Denmark, 24 October 2024 - At the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ) ("ExpreS2ion" or the "Company") on 21 October 2024, it was resolved on a reverse share split of the Company's shares, whereby forty (40) existing shares shall be consolidated into one (1) share (Sw. sammanläggning 1:40). The Board of…

Read more

Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ)

Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") has held an Extraordinary General Meeting 2024 (the "EGM"). Notice of the EGM and complete proposals for resolutions taken are available on the Company's investor website, https://investor.expres2ionbio.com.

Read more

Latest presentations

BioStock Life Science
- From Seed To Success

16 September 2024

Presentation of
half-year results

15 August 2024

2024
Rights Issue Webinar

14 June 2024